CompletedPhase 2

Simufilam (PTI-125), 100 mg, for Mild-to-moderate Alzheimer's Disease Patients

NCT04388254

What is this trial?

Generating plain-language summary...

Generating eligibility summary...

Summarizing study design...

Primary location

Cognitive Clinical Trials

Gilbert, Arizona, United States

+16 additional locations

Save this trial

Cognitive Clinical TrialsGilbert, Arizona, United States
Cognitive Clinical TrialsSurprise, Arizona, United States
Sun Valley Research Center, Inc.Imperial, California, United States
Brain Matters ResearchDelray Beach, Florida, United States
Neuropsychiatric Research Center of Southwest FloridaFort Myers, Florida, United States
Optimus UMiami, Florida, United States
Adaptive Clinical Research, IncMiami Lakes, Florida, United States
IMIC, Inc.Palmetto Bay, Florida, United States
Cognitive Clinical TrialsBellevue, Nebraska, United States
Cognitive Clinical TrialsOmaha, Nebraska, United States
Advanced Memory Research InstituteToms River, New Jersey, United States
Neuro-Behavioral Clinical ResearchNorth Canton, Ohio, United States
Senior Adults Specialty ResearchAustin, Texas, United States
Centex Studies, Inc.Houston, Texas, United States
Centex StudiesMcAllen, Texas, United States
Ottawa Memory ClinicOttawa, Ontario, Canada
Toronto Memory ProgramToronto, Ontario, Canada